Assistance Listing 93.399
Cancer Control
Follow the funding history and Grants.gov notices that share Assistance Listing 93.399.
Historical prime grant obligations
| Assistance Listing | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| 93.399 · Cancer Control | $166,711,884.74 | $166,958,319.73 | $172,107,801.82 |
Filter USAspending award search by Assistance Listing 93.399 to inspect individual awards.
Notices for this program
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) PAR-25-370 · National Institutes of Health · November 16, 2026 · 93.113, 93.121, 93.172, 93.173, 93.242, 93.279, 93.310, 93.313, 93.399, 93.855, 93.865, 93.989
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) PAR-25-369 · National Institutes of Health · November 18, 2026 · 93.113, 93.121, 93.172, 93.173, 93.242, 93.279, 93.310, 93.313, 93.399, 93.853, 93.855, 93.865, 93.867, 93.989
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) PAR-25-371 · National Institutes of Health · November 18, 2026 · 93.113, 93.172, 93.173, 93.242, 93.279, 93.307, 93.310, 93.313, 93.399, 93.853, 93.855, 93.865, 93.867
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-24-214 · National Institutes of Health · January 7, 2027 · 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-25-167 · National Institutes of Health · January 7, 2027 · 93.393, 93.399
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) PAR-25-256 · National Institutes of Health · January 7, 2027 · 93.172, 93.399
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-25-379 · National Institutes of Health · January 7, 2027 · 93.113, 93.121, 93.173, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.879
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) PAR-25-098 · National Institutes of Health · January 7, 2027 · 93.121, 93.307, 93.313, 93.399
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-25-081 · National Institutes of Health · January 7, 2027 · 93.393, 93.394, 93.395, 93.399
- Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) PAR-28-062 · National Institutes of Health · January 25, 2027 · 93.399
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) RFA-CA-28-013 · National Institutes of Health · February 9, 2027 · 93.393, 93.396, 93.399
- Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) PAR-25-317 · National Institutes of Health · March 6, 2027 · 93.273, 93.307, 93.310, 93.313, 93.361, 93.399
- Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) PAR-26-001 · National Institutes of Health · May 7, 2027 · 93.121, 93.273, 93.279, 93.307, 93.313, 93.399
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 · National Institutes of Health · July 12, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 · National Institutes of Health · July 17, 2027 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) PAR-24-330 · National Institutes of Health · September 7, 2027 · 93.233, 93.273, 93.307, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-25-080 · National Institutes of Health · September 7, 2027 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-27-019 · National Institutes of Health · October 19, 2027 · 93.393, 93.394, 93.395, 93.396, 93.399
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) PAR-25-104 · National Institutes of Health · October 25, 2027 · 93.399
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) PAR-25-103 · National Institutes of Health · October 25, 2027 · 93.399
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 · National Institutes of Health · October 25, 2027 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-25-134 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-25-148 · National Institutes of Health · January 7, 2028 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-25-144 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-25-233 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.242, 93.273, 93.279, 93.310, 93.399, 93.853, 93.865, 93.866, 93.989
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-25-143 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.310, 93.361, 93.399, 93.846, 93.853, 93.855, 93.865, 93.866, 93.989
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-25-346 · National Institutes of Health · January 7, 2028 · 93.121, 93.393, 93.394, 93.395, 93.396, 93.399
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-25-321 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.399
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) PAR-25-299 · National Institutes of Health · January 7, 2028 · 93.273, 93.307, 93.399
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-25-043 · National Institutes of Health · January 7, 2028 · 93.393, 93.396, 93.399
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) PAR-25-044 · National Institutes of Health · January 7, 2028 · 93.393, 93.396, 93.399
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PA-25-172 · National Institutes of Health · January 7, 2028 · 93.393, 93.399
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) PA-25-304 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) PA-25-306 · National Institutes of Health · January 7, 2028 · 93.113, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-25-298 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) PAR-25-292 · National Institutes of Health · January 7, 2028 · 93.242, 93.279, 93.307, 93.361, 93.393, 93.396, 93.399, 93.866
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) PA-25-168 · National Institutes of Health · May 4, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.313, 93.351, 93.361, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) PA-25-253 · National Institutes of Health · September 7, 2028 · 93.393, 93.399
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) PAR-25-324 · National Institutes of Health · September 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.397, 93.399
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 · National Institutes of Health · November 30, 2028 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-27-051 · National Institutes of Health · April 17, 2029 · 93.121, 93.242, 93.273, 93.279, 93.399, 93.853
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 · National Institutes of Health · May 7, 2029 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 · National Institutes of Health · May 25, 2029 · 93.113, 93.172, 93.233, 93.273, 93.279, 93.307, 93.313, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.855, 93.866, 93.879
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 · National Institutes of Health · June 20, 2029 · 93.121, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.361, 93.393, 93.394, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.879
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-27-072 · National Institutes of Health · July 5, 2029 · 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.865, 93.867
Source scope
How the records were joined
Grants.gov postings were checked November 10, 2026. Notice details come from the official extract dated November 10, 2026 and the Grants.gov detail service where newer information was available. Deadline comparisons use the same opportunity ID, number and agency across notice versions. A revised date can reflect a new filing cycle. Read the current announcement and package for the deadline that applies to you.
USAspending history groups signed prime grant and cooperative-agreement obligations by exact Assistance Listing and fiscal year. Amendments can reduce a total. An obligation is a commitment. These figures cover the program’s reported transactions across awards and say nothing about available funds or the chance of an award under a particular notice. Missing program-year rows are shown as unavailable. Program figures should be read separately when a notice lists several programs.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.
Grants.gov extracts · Treasury data guide · Treasury API · Download the America.co snapshot